Back

APOE ε4 effects on hippocampal atrophy in the healthy elderly reflect future cognitive decline

Zhang, L.; Calero, M.; Medina, M.; Strange, B.

2022-01-14 neuroscience
10.1101/2022.01.07.475319 bioRxiv
Show abstract

The APOE {varepsilon}4 allele is the primary genetic risk factor for late onset Alzheimers disease (AD). A cardinal problem in determining APOE {varepsilon}4s effect on cognition and brain structure in older individuals is dissociating prodromal changes - linked to increased AD risk - from potential phenotypic differences. To address this, we used cognitive and neuroimaging data from a large cohort of cognitively normal 69-86 year-olds with up to 8 yearly follow-ups to investigate cross-sectional and longitudinal differences between APOE {varepsilon}3/{varepsilon}3 homozygotes and {varepsilon}3/{varepsilon}4 heterozygotes. Although we found a significant age-by-genotype interaction in right hippocampal volume, once our analyses were conditionalised by future diagnosis to account for prodromal mild cognitive impairment (MCI) and AD, this effect was no longer observed. Likewise, longitudinally, rate of hippocampal atrophy was determined not by genotype, but by future diagnosis. Thus, we provide direct evidence in support of the prodromal hypothesis of APOE {varepsilon}4 on brain structure.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.